Northern Trust Corp Pear Therapeutics, Inc. Transaction History

Northern Trust Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.21 - $1.24 $12,381 - $73,111	58,961 Added 11.55%	569,477 $148,000
Q4 2022 Feb 13, 2023	SELL	$0.99 - $2.91 $15,163 - $44,572	-15,317 Reduced 2.91%	510,516 $602,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $2.27 $60,438 - $1.06 Million	464,911 Added 763.12%	525,833 $1.07 Million
Q2 2022 Aug 12, 2022	SELL	$1.54 - $6.48 $1,498 - $6,305	-973 Reduced 1.57%	60,922 $94,000
Q1 2022 May 13, 2022	BUY	$3.67 - $7.63 $227,154 - $472,258	61,895 New	61,895 $313,000

23M

Ticker PEAR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 138,768,992
Market Cap $1.39M
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.